论文部分内容阅读
目的 研究p53 、cerb B2 、PCNA 在宫颈恶性腺瘤中的表达及其诊断价值。方法 采用免疫组织化学方法,检测p53 、cerbB2 和PCNA 在宫颈恶性腺瘤中的表达。结果 p53 、cerbB2 和PCNA 在21 例子宫颈恶性腺瘤中的表达分别为47 .6 % 、4 .7 % 和100 .0 % ,而35 例宫颈良性病变均呈阴性反应。宫颈恶性腺瘤和子宫颈腺癌的p53 、PCNA 阳性率无明显差异。结论 检测p53 、PCNA 有助于子宫颈恶性腺瘤的鉴别诊断。
Objective To study the expression of p53, cerb B2 and PCNA in cervical adenocarcinoma and its diagnostic value. Methods Immunohistochemistry was used to detect the expression of p53, cerbB2 and PCNA in cervical adenocarcinoma. Results The expression of p53, cerbB2 and PCNA in 21 cases of cervical malignant adenoma was 47. 6%, 4. 7% and 100. 0%, while 35 cases of benign cervical lesions were negative. The positive rate of p53 and PCNA in cervical adenocarcinoma and cervical adenocarcinoma had no significant difference. Conclusions Detection of p53 and PCNA contributes to the differential diagnosis of cervical malignant adenoma.